{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:20:38Z","timestamp":1787775638035,"version":"build-2784847793"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The coronavirus disease-2019 (COVID-19) pandemic is one of the most devastating things that happened in the world which has taken the lives of millions of people and has brutally shattered the world economy. This pandemic has instigated an urgent need for a vaccine to reduce the ongoing morbidity and mortality. Bacillus Calmette-Guerin (BCG) apart from being used as an effective and old vaccine against tuberculosis has some known off-target protection effect and is getting more attention in this scenario. BCG confers nonspecific innate immune-boosting effects called trained immunity against secondary infection. Various recent publications have proposed the inverse relationship between the COVID-19 morbidity and mortality with that of BCG coverage of that country on the basis of epidemiological studies. However, these studies have not considered the confounding factors, and a lot of recent articles are contradicting these epidemiological and observational data. Several random control trials for BCG on health-care workers and elderly people are ongoing worldwide and could depict the actual relation between COVID-19 and BCG protection. Although a recent trial has found a protective function of BCG against COVID-19 in health-care workers, more results of the trials can only give approval on this. There has been a shortage of BCG worldwide due to its use in bladder cancer and vaccination in neonates, and hence, its use should be carefully regulated. In this review, we have tried to summarize the various issue and conflicts on BCG to be used as a temporary solution to COVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijmy.ijmy_86_21","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T16:22:23Z","timestamp":1725294143000},"page":"105-110","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Bacillus Calmette-Guerin as a Quick and Temporary Solution to Coronavirus Disease-2019"],"prefix":"10.4103","volume":"10","author":[{"given":"Priyanka","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh Datta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer Suresh","family":"Bhagyawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20240902","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijtb.2020.06.001","article-title":"COVID 19 and tuberculosis","volume":"67","author":"Chopra","year":"2020","journal-title":"Indian J Tuberc"},{"key":"R2-1-20240902","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/infdis\/jiz692","article-title":"Trained immunity confers broad-spectrum protection against bacterial infections","volume":"222","author":"Ciarlo","year":"2020","journal-title":"J Infect Dis"},{"key":"R3-1-20240902","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R4-1-20240902","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"R5-1-20240902","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.celrep.2019.08.004","article-title":"\u03b2-Glucan-Induced trained immunity protects against leishmania braziliensis infection: A crucial role for IL-32","volume":"28","author":"Dos Santos","year":"2019","journal-title":"Cell Rep"},{"key":"R7-1-20240902","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(20)31025-4","article-title":"Considering BCG vaccination to reduce the impact of COVID-19","volume":"395","author":"Curtis","year":"2020","journal-title":"Lancet"},{"key":"R8-1-20240902","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-An update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res"},{"key":"R9-1-20240902","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"R13-1-20240902","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.japh.2016.09.009","article-title":"The vaccine development process","volume":"56","author":"Rolling","year":"2016","journal-title":"J Am Pharm Assoc (2003"},{"key":"R14-1-20240902","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"key":"R15-1-20240902","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1086\/345862","article-title":"Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Gu\u00e9rin attenuation","volume":"187","author":"Lewis","year":"2003","journal-title":"J Infect Dis"},{"key":"R16-1-20240902","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Gu\u00e9rin vaccination of newborns and infants in the prevention of tuberculosis: Meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"R17-1-20240902","first-page":"53","article-title":"History of BCG vaccine","volume":"8","author":"Luca","year":"2013","journal-title":"Maedica (Bucur"},{"key":"R18-1-20240902","doi-asserted-by":"crossref","first-page":"20130428","DOI":"10.1098\/rstb.2013.0428","article-title":"Human genetics of tuberculosis: A long and winding road","volume":"369","author":"Abel","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R19-1-20240902","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/trstmh\/tru168","article-title":"Trained immunity: Consequences for the heterologous effects of BCG vaccination","volume":"109","author":"Kleinnijenhuis","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R20-1-20240902","doi-asserted-by":"crossref","first-page":"i5170","DOI":"10.1136\/bmj.i5170","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: Systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"key":"R21-1-20240902","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2013-2218","article-title":"Acute lower respiratory infection among Bacille Calmette-Gu\u00e9rin (BCG)-vaccinated children","volume":"133","author":"Hollm-Delgado","year":"2014","journal-title":"Pediatrics"},{"key":"R22-1-20240902","first-page":"185","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta Med Indones"},{"key":"R23-1-20240902","doi-asserted-by":"crossref","first-page":"668","DOI":"10.7150\/ijms.12233","article-title":"The association of BCG vaccination with atopy and asthma in adults","volume":"12","author":"Park","year":"2015","journal-title":"Int J Med Sci"},{"key":"R24-1-20240902","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ije\/dyp307","article-title":"Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies","volume":"39","author":"El-Zein","year":"2010","journal-title":"Int J Epidemiol"},{"key":"R25-1-20240902","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/S0264-410X(03)00181-6","article-title":"BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?","volume":"21","author":"Garly","year":"2003","journal-title":"Vaccine"},{"key":"R26-1-20240902","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: Beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"J Infect Dis"},{"key":"R27-1-20240902","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: A beneficial effect of BCG vaccination for girls community based case-control study","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine"},{"key":"R28-1-20240902","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"key":"R29-1-20240902","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/cid\/cix525","article-title":"Early BCG-Denmark and neonatal mortality among infants weighing<2500 g: A randomized controlled trial","volume":"65","author":"Biering-S\u00f8rensen","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R30-1-20240902","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3143\/geriatrics.42.34","article-title":"Prevention of elderly pneumonia by pneumococcal, influenza and BCG vaccinations","volume":"42","author":"Ohrui","year":"2005","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"R31-1-20240902","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis","volume":"60","author":"de Castro","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R32-1-20240902","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cell.2020.04.042","article-title":"Trained immunity: A tool for reducing susceptibility to and the severity of SARS-CoV-2 infection","volume":"181","author":"Netea","year":"2020","journal-title":"Cell"},{"key":"R33-1-20240902","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J Innate Immun"},{"key":"R34-1-20240902","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: A memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"R35-1-20240902","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: A program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"R36-1-20240902","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","article-title":"BCG-induced trained immunity: Can it offer protection against COVID-19?","volume":"20","author":"O'Neill","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"R38-1-20240902","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3389\/fimmu.2020.00970","article-title":"Could BCG vaccination induce protective trained immunity for SARS-CoV-2?","volume":"11","author":"Covi\u00e1n","year":"2020","journal-title":"Front Immunol"},{"key":"R42-1-20240902","doi-asserted-by":"crossref","first-page":"e00907","DOI":"10.1128\/mBio.00907-20","article-title":"Could an unrelated live attenuated vaccine serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection?","volume":"11","author":"Fidel","year":"2020","journal-title":"mBio"},{"key":"R43-1-20240902","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.chom.2012.06.006","article-title":"Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes","volume":"12","author":"Quintin","year":"2012","journal-title":"Cell Host Microbe"},{"key":"R44-1-20240902","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/resp.13885","article-title":"National policies for paediatric universal BCG vaccination were associated with decreased mortality due to COVID-19","volume":"25","author":"Ebina-Shibuya","year":"2020","journal-title":"Respirology"},{"key":"R45-1-20240902","doi-asserted-by":"crossref","first-page":"109816","DOI":"10.1016\/j.mehy.2020.109816","article-title":"Relation between BCG coverage rate and COVID-19 infection worldwide","volume":"142","author":"Macedo","year":"2020","journal-title":"Med Hypotheses"},{"key":"R46-1-20240902","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1073\/pnas.2008410117","article-title":"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)","volume":"117","author":"Escobar","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R47-1-20240902","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.puhe.2020.05.042","article-title":"TB infection and BCG vaccination: Are we protected from COVID-19?","volume":"185","author":"Madan","year":"2020","journal-title":"Public Health"},{"key":"R48-1-20240902","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cegh.2020.08.015","article-title":"Is BCG associated with reduced incidence of COVID-19? A meta-regression of global data from 160 countries","volume":"9","author":"Joy","year":"2021","journal-title":"Clin Epidemiol Glob Health"},{"key":"R49-1-20240902","first-page":"207","article-title":"Stop playing with data: There is no sound evidence that Bacille Calmette-Gu\u00e9rin may avoid SARS-CoV-2 infection (for now)","volume":"91","author":"Ricc\u00f2","year":"2020","journal-title":"Acta Biomed"},{"key":"R50-1-20240902","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12098-020-03371-3","article-title":"BCG vaccination policy and protection against COVID-19","volume":"87","author":"Meena","year":"2020","journal-title":"Indian J Pediatr"},{"key":"R51-1-20240902","doi-asserted-by":"crossref","first-page":"18377","DOI":"10.1038\/s41598-020-75491-x","article-title":"Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses","volume":"10","author":"Hensel","year":"2020","journal-title":"Sci Rep"},{"key":"R52-1-20240902","doi-asserted-by":"crossref","first-page":"e12661","DOI":"10.15252\/emmm.202012661","article-title":"Is BCG vaccination causally related to reduced COVID-19 mortality?","volume":"12","author":"Miyasaka","year":"2020","journal-title":"EMBO Mol Med"},{"key":"R53-1-20240902","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1874306402014010045","article-title":"BCG vaccine does not protect against COVID-19","volume":"14","author":"Allam","year":"2020","journal-title":"Open Respir Med J"},{"key":"R54-1-20240902","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2020.8189","article-title":"SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults","volume":"323","author":"Hamiel","year":"2020","journal-title":"JAMA"},{"key":"R55-1-20240902","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00345-020-03251-7","article-title":"BCG versus COVID-19: Impact on urology","volume":"39","author":"Desouky","year":"2021","journal-title":"World J Urol"},{"key":"R56-1-20240902","doi-asserted-by":"crossref","first-page":"642","DOI":"10.5588\/ijtld.20.0240","article-title":"Concern over a COVID-19-related BCG shortage","volume":"24","author":"Namkoong","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"R57-1-20240902","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1097\/INF.0000000000002724","article-title":"Demand for BCG vaccine due to unproven claims of its role in preventing COVID-19 Is causing shortages of vaccines for infants in Japan","volume":"39","author":"Kuroda","year":"2020","journal-title":"Pediatr Infect Dis J"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_86_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:37:11Z","timestamp":1787773031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_86_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_86_21","relation":{},"ISSN":["2212-5531"],"issn-type":[{"value":"2212-5531","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}